Sanjay Suri
Tracked across 2 events · 12 articles · First seen Apr 17, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Sanjay Suri, Managing Director of Abbott Laboratories Limited, commented on the development, highlighting its importance for the company's strategic direction.
Jul 01, 2026 · 6 articles
Regulatory
Impact: Sanjay Suri, Executive Director and CEO (API) of Abbott Laboratories, emphasized that the consistent track record of NIL 483 inspections strengthens the company's credibility and global orders pipeline.
Apr 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Sanjay Suri live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard